Human myocardial morphologic and functional changes in the first 24 hours after doxorubicin administration

Area of Science:

• Cardiology
• Oncology
• Cell Biology

Background:

• Doxorubicin is a widely used chemotherapy agent.
• Cardiac toxicity is a significant concern with doxorubicin treatment.
• Understanding early cellular changes is crucial for managing cardiotoxicity.

Purpose of the Study:

• To document early structural alterations in the human heart following doxorubicin administration.
• To correlate structural changes with early functional assessments.

Main Methods:

• Endomyocardial biopsies from 13 patients at baseline, 4, and 24 hours post-doxorubicin.
• Morphometric analysis of electron micrographs to quantify mitochondrial and tubular sizes.
• Assessment of nuclear morphology for cellular damage.
• Serial echocardiography and systolic time intervals to evaluate left ventricular function.

Main Results:

• Mitochondrial size showed a non-significant increase.
• Tubular structures (sarcoplasmic reticulum and T tubules) demonstrated a significant size increase at 4 hours (P < 0.05).
• Nuclear changes, including nucleolar contraction, were observed in a majority of patients by 24 hours.
• Left ventricular function significantly improved at both 4 and 24 hours.

Conclusions:

• Doxorubicin's primary early effect is on cardiac tubular structures.
• Despite observed structural changes, left ventricular function improved within the first 24 hours of doxorubicin administration.
• Early monitoring of cardiac structure and function is essential during doxorubicin therapy.